Chief Executive Officer
CurrentUnleashing the power of adenosine to improve human health. Developing novel, best-in-class molecules targeting the adenosine receptors.
Please complete the CAPTCHA to continue
@stilley.net
✓
7 phones found area 434 and 804
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
William Stilley is listed as CEO of Adovate at Adovate, based in Charlottesville, Virginia, United States. AeroLeads shows a work email signal at stilley.net, phone signal with area code 434, 804, and a matched LinkedIn profile for William Stilley.
William Stilley previously worked as Chief Executive Officer at Adovate and Board Member; Chair of Audit Committee at Avalon Globocare Corp (Nasdaq: Avco). William Stilley holds Master Of Business Administration (M.B.A.), Finance & Strategy from University Of Virginia Darden School Of Business.
This section adds company-level context without repeating William Stilley's masked contact details.
AeroLeads found 1 current-domain work email signal for William Stilley. Compare company email patterns before reaching out.
Life Science & Finance Executive. Former NASDAQ CEO. CFO of multiple companies. Public Company Board Member & Audit Committee Chair.
Listed skills include Strategy, Pharmaceutical Industry, Start Ups, Mergers And Acquisitions, and 19 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Charlottesville, VA, US
Unleashing the power of adenosine to improve human health. Developing novel, best-in-class molecules targeting the adenosine receptors.
Leader in the fields of immune effector cell therapy (including CAR-T and CAR-NK), exosome-based regenerative therapeutics (our ACTEXTM platform), as well as "liquid biopsy" diagnostics.http://avalon-globocare.com/
Board Member Sep 2012-Dec 2020Advisory Board Jan 2020-Present
Wholly owned subsidiary of Adial Pharmaceuticals (Nasdaq:ADIL) focused on developing drug candidates using its adenosine platform.
Palo Alto, CA, US
Block chain technologies and cryptocurrency.https://sysorexinc.com/
Charlottesville, Virginia, US
Developed drugs for addiction diseases and disorders. Pipeline included AD04, Phase 3 drug candidate for the treatment for Alcohol Use Disorder (AUD) in genetically targeted patients, and drug candidates based from its adenosine platform targeted for the treatment of pain, cancer, diabetes, asthma, wound healing, and inflammatory disorders.
Charlottesville, VA, US
Taught classes in the course Emerging Medical Technology and the course Transactions & Deal Making in the Life Scienses. Class topics are focused on strategy, valuation, financing, and value creation.
US
Focused on licensing, M&A, contracting & management of pre-clinical development to global Phase 3 clinical trials, and contracting manufacture of commercial supplies for the launch and commercialization of Viibryd. Patent holder for Stedivaze, Phase 3 for cardiac stress drug for SPECT.In August 2008, PGxHealth, a division of Clinical Data, Inc. (NASDQ.
Company was a world leader in the discovery and development of drugs targeted against adenosine receptors. Ran all company operations (including R&D from discovery to late stage clinical development), finance, and acquisitions and key person on all deals. Significant in-licensing and out-licensing activity. Inventor of Stedivaze, a drug currently in Phase.
Consulting for a number of companies across a diverse industry set.
Founded company that was acquired by Cottage Investments, Inc. (NASDAQ: COTF). Served in role of CFO after acquiring management was removed in 2000. Restructured company and sold it in December 2001.
Founded industrial braking and clutching consolidation company. Sold to BB&T Capital Partners simultaneous with acquisition of the Cline Company in August 1998.
Washington, DC, US
Infantry Platoon Commander, Adjutant, Company Commander, General's Aide-de-camp.
Quick answers generated from the profile data available on this page.
William Stilley works for Adovate.
William Stilley is listed as CEO of Adovate at Adovate.
AeroLeads has found 1 work email signal at @stilley.net for William Stilley at Adovate.
AeroLeads has found 7 phone signal(s) with area code 434, 804 for William Stilley at Adovate.
William Stilley is based in Charlottesville, Virginia, United States while working with Adovate.
William Stilley has worked for Adovate, Avalon Globocare Corp (Nasdaq: Avco), Virginia Biotechnology Association, Purnovate, Inc., and Sysorex - Now Inpixon.
You can use AeroLeads to view verified contact signals for William Stilley at Adovate, including work email, phone, and LinkedIn data when available.
William Stilley holds Master Of Business Administration (M.B.A.), Finance & Strategy from University Of Virginia Darden School Of Business.
William Stilley is listed with skills including Strategy, Pharmaceutical Industry, Start Ups, Mergers And Acquisitions, Business Development, Strategic Planning, Commercialization, and Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts